Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Trading Statement

9 Jul 2010 07:00

RNS Number : 0904P
Charlemagne Capital Limited
09 July 2010
 



9 July 2010

 

 

Charlemagne Capital Announces Unaudited Revenues and Assets under Management for the Six Months Ended 30 June 2010

 

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the key revenue items and Assets under Management ("AuM") for the first six months of its current financial year. It is expected that the interim financial results will be announced on 7 September 2010.

 

Key highlights and Group AuM

 

§ Group AuM US$2.8 billion in total at 30 June 2010, up by 16% on June 2009, down 9.5% since 1 January 2010.

 

§ Net management fees up 24% on same period last year and 1% on previous six months.

 

§ Overall decline in emerging markets in the first half of the year following the fall in global equities markets during the second quarter.

 

§ The Group remains well-capitalised and is continuing to invest in building the business.

 

The table below sets out the Group's AuM as at 30 June 2010 and the movements experienced in each product range in the period since 1 January 2010.

 

01-Jan-10

Net Subscriptions

Reorganisation

Net Performance

30-Jun-10

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

562

(48)

(8.5)

-

-

(39)

(7.2)

475

(15.5)

OCCO

105

60

57.1

-

-

10

7.4

175

66.7

Institutional Advisory

912

(43)

(4.7)

-

-

(75)

(8.4)

 

794

(12.9)

Institutional Mandates

1,234

(43)

(3.5)

(3)

(0.2)

(82)

(6.8)

 

1,106

(10.4)

Specialist

239

17

7.1

-

-

(45)

(18.2)

211

(11.7)

Total

3,052

(57)

(1.9)

(3)

(0.1)

(231)

(7.6)

2,761

(9.5)

 

Notes

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2010

 

Net management fees receivable were US$10.4 million compared with US$8.4 million for the first six months of 2009, reflecting the higher average AuM in the first half of 2010.

 

Crystallised performance fees were US$3.8 million compared with US$0.3 million for the comparative period in 2009. As previously announced, US$3.7 million of crystallised performance fees received in the period relate to the distribution of the net assets of SWR Investments Limited, a jointly controlled entity now in the process of being wound up.

 

Accruing performance fees for 2010 which have not crystallised were US$2.1 million compared with US$0.9 million as at the same date in 2009. Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the Group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

 

Dividend

 

In the absence of unforeseen circumstances, the Group intends to declare an Ordinary and a Special Interim dividend in respect of the six months to 30 June 2010. Further details will be provided in the interim results announcement.

 

Summary

 

The period has seen declines in emerging market indices and the Group has experienced modest net outflows during the period. However it is encouraging to note that the OCCO product is attracting strong and continuing inflows and the Group has again recommenced fund raising for property (specialist) investments. Outflows within the institutional mandate category were largely caused by the enforced rebalancing of mandates and there were no client losses. In the last week of the half year, two new Magna sub funds were launched, the Undervalued Assets Fund and the Emerging Markets Dividend Fund.

 

Emerging market equities lost ground in the second quarter of this year following the recovery made in 2009 and the first quarter of 2010. The asset class as a whole lost 8% in the quarter and around 6% in the first half of the year. This is due to a combination of global and market-specific factors. Globally, fears of a broadening of the Greek sovereign crisis frightened some investors. Furthermore, investors continued to fret about the slowing Chinese economy which negatively impacted commodities markets. There is however growing evidence that the policy tightening in China is succeeding and may be coming to a close.  Charlemagne's investment performance in key areas has improved in the last twelve months and we are confident that this, together with some degree of normalisation in markets, will lead to improved business flows going forward.

 

 

Enquiries:

 

Charlemagne Capital

 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Chief Financial Officer

Tel. 01624 640200

 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

 

Gemma Froggatt

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDRXSGBGGI
Date   Source Headline
4th Sep 20067:02 amRNSInterim Results
14th Aug 200612:00 pmRNSNotice of Interim Results
2nd Aug 20063:58 pmRNSDividend Payment Document
10th Jul 20067:00 amRNSTrading Statement
13th Jun 20067:02 amRNSMagna Asia Fund Launch
7th Jun 20067:00 amRNSTransaction in Own Shares
2nd Jun 20067:01 amRNSTransaction in Own Shares
30th May 20067:01 amRNSTransaction in Own Shares
25th May 20064:15 pmRNSDirector/PDMR Shareholding
23rd May 200612:25 pmRNSDirector/PDMR Shareholding
22nd May 20061:47 pmRNSResult of AGM
22nd May 20067:00 amRNSAGM Statement
8th May 20069:00 amRNSAuM update
5th May 20069:32 amRNSNotice of AGM
10th Apr 20067:02 amRNSQuarterly Update
30th Mar 200611:13 amRNSSch 1 Update - Charlemagne

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.